CIEC
AVDL

Crédit Industriel et Commercial’s Avadel Pharmaceuticals AVDL Stock Holding History

Crédit Industriel et Commercial’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-522,034
Closed -$11.2M – 361
2025
Q4 		$11.2M Buy
+522,034
New +$10.1M 0.86% 27

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Crédit Industriel et Commercial's AVDL Position: Q1 2026 in Review

Crédit Industriel et Commercial sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 522,034 shares — an estimated $11.2M sold.

Crédit Industriel et Commercial first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $11.2M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Crédit Industriel et Commercial reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Crédit Industriel et Commercial sold 522,034 Avadel Pharmaceuticals shares in Q1 2026, an estimated $11.2M.
  • Crédit Industriel et Commercial first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Crédit Industriel et Commercial's Avadel Pharmaceuticals position peaked at $11.2M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q1 2026, filed 29 Apr 2026.